Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation
Fabrizio Piazza, Davide Donato Lucia, Francesca Guzzi, Rosario Pascarella, Elisabetta DeBernardi, Laura Antolini, Gianpaolo Basso, Marialuisa Zedde, The CAA‐SINdem Study Group and The iCAB International Network Research Group · 2025
Read Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation by Fabrizio Piazza, Davide Donato Lucia, Francesca Guzzi, Rosario Pascarella, Elisabetta DeBernardi, Laura Antolini, Gianpaolo Basso, Marialuisa Zedde, The CAA‐SINdem Study Group and The iCAB International Network Research Group (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709991.txt.
Description
Fabrizio Piazza and co-authors argued in 2025 that a side effect of Alzheimer's antibody drugs mirrors a rare natural brain disease. The side effect shows as swelling or bleeding on scans during treatment that lowers amyloid. The natural twin is an immune attack linked to amyloid in vessel walls.
Years of network data back the match: the two share course, response to steroid care, and spots where scans light up beside immune cell activity. The natural disease also carries self-made antibodies against amyloid in spinal fluid. Testing for those may flag risk early in trials and in real care. A new global registry and biobank aims to track both forms over time.
Catalog record
| CREATOR | Fabrizio Piazza, Davide Donato Lucia, Francesca Guzzi, Rosario Pascarella, Elisabetta DeBernardi, Laura Antolini, Gianpaolo Basso, Marialuisa Zedde, The CAA‐SINdem Study Group and The iCAB International Network Research Group |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |